citalopram has been researched along with methylphenidate in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 17 (40.48) | 29.6817 |
| 2010's | 22 (52.38) | 24.3611 |
| 2020's | 3 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Bergström, F; Giordanetto, F; Rehngren, M; Tunek, A; Wan, H | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Kumar, A; Lavretsky, H | 1 |
| Heyman, I; Woolley, JB | 1 |
| Kim, MD; Kumar, A; Lavretsky, H; Reynolds, CF | 1 |
| Fukushima, S; Hall, FS; Kobayashi, H; Numachi, Y; Shen, HW; Sora, I; Uhl, GR; Yamashita, M | 1 |
| Kumar, A; Lavretsky, H; Park, S; Reynolds, CF; Siddarth, P | 1 |
| Kehr, J; Weikop, P; Yoshitake, T | 1 |
| Deutsch, HM; Kim, DI; Schweri, MM; Ye, X | 1 |
| Kumar, A; Lavretsky, H; Reynolds, CF; Siddarth, P | 1 |
| Kehr, J; Scheel-Krüger, J; Weikop, P | 1 |
| Fahey, MA; Fryer, AK; Lynch, L; Madras, BK; Miller, GM; Verrico, CD | 1 |
| Aagaard, L; Hansen, EH; Thirstrup, S | 1 |
| Arciniegas, DB; McAllister, TW; Silver, JM | 1 |
| Auyeung, SF; Lawson, D; Long, Q; Manatunga, A; McNutt, MD; Miller, A; Murthy, S; Musselman, DL; Royster, EB | 1 |
| Beverley, J; Marinelli, M; Steiner, H; Van Waes, V | 1 |
| Bellgrove, MA; Cummins, TD; Dean, AJ; Garner, K; Hester, R; Kim, BN; Mattingley, JB; Nandam, LS; Nathan, PJ; Wagner, J | 1 |
| Bellgrove, MA; Hester, R; Mattingley, JB; Nandam, LS; Nathan, PJ; O'Connell, RG; Strudwick, M; Wagner, J | 1 |
| Barnes, JJ; Bellgrove, MA; Dean, AJ; Nandam, LS; O'Connell, RG | 1 |
| Spada, MM | 1 |
| Anagnostaras, SG; Carmack, SA; Howell, KK; Rasaei, K; Reas, ET | 1 |
| Bellgrove, MA; Hester, R; Nandam, LS | 1 |
| Ercoli, LM; Lavretsky, H; Reinlieb, M; Senturk, D; Siddarth, P; St Cyr, N | 1 |
| Nelson, JC | 1 |
| Roose, S; Rutherford, B | 1 |
| Lavretsky, H | 1 |
| Baune, BT; Eskin, A; Eyre, HA; Lavretsky, H; Nelson, SF; Siddarth, P; St Cyr, NM | 1 |
| Bader, M; Pick, CG; Rubovitch, V; Schreiber, S | 1 |
| George, AK; Mann, RA | 1 |
| Laird, KT; Lavretsky, H; Siddarth, P; St Cyr, N | 1 |
| Barnes, JJM; Bellgrove, MA; Brosnan, MB; Dean, A; Loughnane, GM; Nandam, SL; O'Connell, RG | 1 |
| Brotman, MA; Davis, M; Engel, C; Haring, CT; Kaiser, A; Lee, B; Leibenluft, E; McNeil, C; Miller, KV; Overman, GP; Pickles, A; Pine, DS; Roule, A; Sharif-Askary, B; Stringaris, A; Towbin, K; Vidal-Ribas, P; Vitale, AD; Wambach, CG; Wheeler, W; Yokum, CH | 1 |
| Britt, RB; Brown, JN; Kahlon, CH; Smith, KR | 1 |
| Andrillon, T; Bellgrove, MA; Dockree, PM; O'Connell, RG; Pinggal, E | 1 |
4 review(s) available for citalopram and methylphenidate
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Depression and cognitive complaints following mild traumatic brain injury.
Topics: Antidepressive Agents, Tricyclic; Brain; Brain Injuries; Central Nervous System Stimulants; Choline; Citalopram; Cognition Disorders; Cognitive Behavioral Therapy; Depression; Humans; Methylphenidate; Neuropsychological Tests; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index | 2009 |
An overview of problematic internet use.
Topics: Antidepressive Agents, Second-Generation; Behavior, Addictive; Central Nervous System Stimulants; Citalopram; Cognitive Behavioral Therapy; Comorbidity; Disruptive, Impulse Control, and Conduct Disorders; Humans; Internet; Methylphenidate; Mood Disorders; Naltrexone; Narcotic Antagonists; Prevalence; Substance-Related Disorders | 2014 |
Methylphenidate use in geriatric depression: A systematic review.
Topics: Aged; Citalopram; Depression; Depressive Disorder, Major; Humans; Methylphenidate; Middle Aged; Prospective Studies; Randomized Controlled Trials as Topic; Treatment Outcome | 2021 |
13 trial(s) available for citalopram and methylphenidate
| Article | Year |
|---|---|
Combined treatment with methylphenidate and citalopram for accelerated response in the elderly: an open trial.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Central Nervous System Stimulants; Chronic Disease; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Methylphenidate; Personality Inventory; Recurrence | 2003 |
Methylphenidate-enhanced antidepressant response to citalopram in the elderly: a double-blind, placebo-controlled pilot trial.
Topics: Aged; Central Nervous System Stimulants; Citalopram; Cognition Disorders; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Methylphenidate; Neuropsychological Tests; Pilot Projects; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Surveys and Questionnaires | 2006 |
The effects of the dopamine and serotonin transporter polymorphisms on clinical features and treatment response in geriatric depression: a pilot study.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Central Nervous System Stimulants; Citalopram; Depressive Disorder, Major; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methylphenidate; Pilot Projects; Polymorphism, Genetic; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Treatment Outcome | 2008 |
Methylphenidate but not atomoxetine or citalopram modulates inhibitory control and response time variability.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Citalopram; Cross-Over Studies; Dopamine Uptake Inhibitors; Double-Blind Method; Humans; Inhibition, Psychological; Male; Methylphenidate; Neuropsychological Tests; Propylamines; Reaction Time; Selective Serotonin Reuptake Inhibitors | 2011 |
Neurochemical enhancement of conscious error awareness.
Topics: Adolescent; Adult; Analysis of Variance; Atomoxetine Hydrochloride; Awareness; Brain Mapping; Central Nervous System Stimulants; Citalopram; Consciousness; Cross-Over Studies; Double-Blind Method; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Inhibition, Psychological; Magnetic Resonance Imaging; Male; Methylphenidate; Neuropsychological Tests; Oxygen; Parietal Lobe; Photic Stimulation; Propylamines; Reaction Time; Time Factors; Young Adult | 2012 |
Monoaminergic modulation of behavioural and electrophysiological indices of error processing.
Topics: Adrenergic Uptake Inhibitors; Atomoxetine Hydrochloride; Citalopram; Cross-Over Studies; Dopamine Uptake Inhibitors; Double-Blind Method; Evoked Potentials; Executive Function; Female; Humans; Male; Methylphenidate; Neuropsychological Tests; Propylamines; Psychomotor Performance; Reaction Time; Selective Serotonin Reuptake Inhibitors; Young Adult | 2014 |
Dissociable and common effects of methylphenidate, atomoxetine and citalopram on response inhibition neural networks.
Topics: Adolescent; Adult; Atomoxetine Hydrochloride; Awareness; Brain; Citalopram; Double-Blind Method; Executive Function; Humans; Image Processing, Computer-Assisted; Inhibition, Psychological; Magnetic Resonance Imaging; Male; Methylphenidate; Neural Pathways; Neuropsychological Tests; Neurotransmitter Agents; Oxygen; Propylamines; Visual Analog Scale; Young Adult | 2014 |
Citalopram, methylphenidate, or their combination in geriatric depression: a randomized, double-blind, placebo-controlled trial.
Topics: Aged; Anxiety Disorders; Apathy; Citalopram; Cognition Disorders; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Methylphenidate; Middle Aged; Personality Assessment; Psychometrics; Quality of Life | 2015 |
Genomic predictors of remission to antidepressant treatment in geriatric depression using genome-wide expression analyses: a pilot study.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Dopamine Uptake Inhibitors; Drug Therapy, Combination; Female; Genetic Predisposition to Disease; Genome-Wide Association Study; Humans; Induction Chemotherapy; Male; Methylphenidate; Middle Aged; Pilot Projects; Psychiatric Status Rating Scales | 2016 |
Resilience predicts remission in antidepressant treatment of geriatric depression.
Topics: Adaptation, Psychological; Aged; Aged, 80 and over; Antidepressive Agents; Citalopram; Depressive Disorder; Female; Geriatric Psychiatry; Humans; Logistic Models; Male; Methylphenidate; Middle Aged; Resilience, Psychological; Self Efficacy; Treatment Outcome | 2018 |
Catecholamine Modulation of Evidence Accumulation during Perceptual Decision Formation: A Randomized Trial.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Atomoxetine Hydrochloride; Brain; Catecholamines; Citalopram; Cross-Over Studies; Decision Making; Dopamine Uptake Inhibitors; Double-Blind Method; Electroencephalography; Evoked Potentials, Visual; Humans; Male; Methylphenidate; Middle Aged; Selective Serotonin Reuptake Inhibitors; Visual Perception; Young Adult | 2019 |
A Double-Blind Randomized Placebo-Controlled Trial of Citalopram Adjunctive to Stimulant Medication in Youth With Chronic Severe Irritability.
Topics: Adolescent; Attention Deficit and Disruptive Behavior Disorders; Central Nervous System Stimulants; Citalopram; Double-Blind Method; Humans; Irritable Mood; Methylphenidate; Treatment Outcome | 2020 |
Pharmacological Manipulations of Physiological Arousal and Sleep-Like Slow Waves Modulate Sustained Attention.
Topics: Atomoxetine Hydrochloride; Attention; Citalopram; Dopamine; Electroencephalography; Humans; Male; Methylphenidate; Norepinephrine; Serotonin; Sleep; Wakefulness | 2022 |
25 other study(ies) available for citalopram and methylphenidate
| Article | Year |
|---|---|
High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery.
Topics: Animals; Brain; Central Nervous System Agents; Dialysis; Hydrophobic and Hydrophilic Interactions; In Vitro Techniques; Mice; Models, Statistical; Protein Binding; Quantitative Structure-Activity Relationship; Rats | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Methylphenidate augmentation of citalopram in elderly depressed patients.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Central Nervous System Stimulants; Citalopram; Depressive Disorder, Major; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Methylphenidate | 2001 |
Dexamphetamine for obsessive-compulsive disorder.
Topics: Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Citalopram; Depression; Dextroamphetamine; Drug Therapy, Combination; Humans; Male; Methylphenidate; Obsessive-Compulsive Disorder; Recurrence | 2003 |
Norepinephrine transporter blockade can normalize the prepulse inhibition deficits found in dopamine transporter knockout mice.
Topics: Acoustic Stimulation; Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Behavior, Animal; Central Nervous System Stimulants; Citalopram; Cocaine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Fluoxetine; Inhibition, Psychological; Male; Methylphenidate; Mice; Mice, Inbred C57BL; Mice, Knockout; Norepinephrine Plasma Membrane Transport Proteins; Reaction Time; Reflex, Startle; Selective Serotonin Reuptake Inhibitors | 2006 |
Differential effects of adjunctive methylphenidate and citalopram on extracellular levels of serotonin, noradrenaline and dopamine in the rat brain.
Topics: Animals; Behavior, Animal; Biogenic Monoamines; Brain; Citalopram; Dopamine; Drug Interactions; Extracellular Fluid; Male; Methylphenidate; Microdialysis; Motor Activity; Neurotransmitter Uptake Inhibitors; Norepinephrine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Time Factors | 2007 |
Synthesis and pharmacology of site-specific cocaine abuse treatment agents: restricted rotation analogues of methylphenidate.
Topics: Animals; Brain; Bridged Bicyclo Compounds, Heterocyclic; Citalopram; Cocaine; Cocaine-Related Disorders; Dopamine; Dopamine Plasma Membrane Transport Proteins; Fluoxetine; In Vitro Techniques; Male; Methylphenidate; Quinolizines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Serotonin Plasma Membrane Transport Proteins; Stereoisomerism; Structure-Activity Relationship | 2007 |
Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.
Topics: Adrenergic Uptake Inhibitors; Animals; Citalopram; Cyclohexanols; Dopamine; Dopamine Uptake Inhibitors; Male; Methylphenidate; Microdialysis; Norepinephrine; Piperazines; Prefrontal Cortex; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 2007 |
MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor.
Topics: Administration, Oral; Animals; Appetitive Behavior; Association Learning; Cell Line; Citalopram; Desipramine; Discrimination Learning; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Injections, Intramuscular; Macaca fascicularis; Male; Mental Recall; Methylphenidate; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine Plasma Membrane Transport Proteins; Reversal Learning; Serotonin Plasma Membrane Transport Proteins; Stereotyped Behavior | 2008 |
Opening the white boxes: the licensing documentation of efficacy and safety of psychotropic medicines for children.
Topics: Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Child; Child, Preschool; Citalopram; Drug and Narcotic Control; Humans; Infant; Infant, Newborn; Licensure; Methylphenidate; Psychotropic Drugs | 2009 |
Sequential multiple-assignment randomized trial design of neurobehavioral treatment for patients with metastatic malignant melanoma undergoing high-dose interferon-alpha therapy.
Topics: Behavioral Symptoms; Citalopram; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Humans; Injections, Subcutaneous; Interferon-alpha; Melanoma; Methylphenidate; Mood Disorders; Neoplasm Metastasis; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Serotonin Antagonists; Syndrome | 2009 |
Selective serotonin reuptake inhibitor antidepressants potentiate methylphenidate (Ritalin)-induced gene regulation in the adolescent striatum.
Topics: Analysis of Variance; Animals; Autoradiography; Citalopram; Corpus Striatum; Dopamine Uptake Inhibitors; Early Growth Response Protein 1; Fluoxetine; Gene Expression; In Situ Hybridization; Male; Methylphenidate; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; RNA, Messenger; Selective Serotonin Reuptake Inhibitors | 2010 |
Animal model of methylphenidate's long-term memory-enhancing effects.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Atomoxetine Hydrochloride; Bupropion; Central Nervous System Stimulants; Citalopram; Cocaine; Conditioning, Classical; Dose-Response Relationship, Drug; Fear; Female; Locomotion; Male; Maze Learning; Memory, Long-Term; Methylphenidate; Mice; Mice, Inbred C57BL; Nootropic Agents; Propylamines; Reinforcement, Psychology; Selective Serotonin Reuptake Inhibitors; Space Perception | 2014 |
The role of stimulants in late-life depression.
Topics: Citalopram; Depressive Disorder, Major; Female; Humans; Male; Methylphenidate | 2015 |
Cardiac Effects of Methylphenidate.
Topics: Citalopram; Depressive Disorder, Major; Female; Humans; Male; Methylphenidate | 2015 |
Response to Roose and Rutherford.
Topics: Citalopram; Depressive Disorder, Major; Female; Humans; Male; Methylphenidate | 2015 |
Interaction between methylphenidate, methadone and different antidepressant drugs on antinociception in mice, and possible clinical implications.
Topics: Analgesics, Opioid; Animals; Antidepressive Agents; Central Nervous System Stimulants; Citalopram; Drug Interactions; Male; Methadone; Methylphenidate; Mice; Mice, Inbred ICR; Nociception | 2017 |
Recurrent Priapism in a Military Veteran Receiving Treatment for PTSD.
Topics: Adult; Citalopram; Humans; Male; Methylphenidate; Prazosin; Priapism; Psychotropic Drugs; Stress Disorders, Post-Traumatic; Trazodone; Veterans | 2017 |